Synapses and Neuromuscular Control

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/33

flashcard set

Earn XP

Description and Tags

Flashcards on Synapses, Neuromuscular Control, and Nervous System Disorders

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

34 Terms

1
New cards

Electrical Synapses

Electric current passes directly from pre- to postsynaptic cell through gap junctions.

2
New cards

Chemical Synapses

Electrical signal is converted into a chemical signal that is released from the presynaptic cell and acts on receptors on the postsynaptic cell.

3
New cards

Gap Junctions

Intercellular channel formed by the docking of two hemichannels composed of connexin or innexin proteins.

4
New cards

Classical Neurotransmitter Example

Acetylcholine

5
New cards

Biogenic Amines

Noradrenaline, dopamine, serotonin, histamine

6
New cards

Amino Acid Neurotransmitters

Glutamate, GABA, glycine

7
New cards

Peptide Neurotransmitters

Substance P, Opioids (endorphins, enkephalins)

8
New cards

Unconventional Neurotransmitters

Nitric oxide (NO), adenosine triphosphate (ATP), cannabinoids

9
New cards

Excitatory Neurotransmitter

Excites the postsynaptic cell by depolarizing the membrane.

10
New cards

Inhibitory Neurotransmitter

Inhibits the postsynaptic cell by hyperpolarizing the membrane.

11
New cards

Neurotransmitter Release - Regulated Exocytosis

Action potential depolarizes axon terminal, Ca2+ enters, exocytosis of synaptic vesicle contents, neurotransmitter binds to postsynaptic receptors, postsynaptic cell response.

12
New cards

Acetylcholine Synthesis Enzyme

Choline acetyltransferase catalyzes transfer of acetyl group from acetyl CoA to choline to make acetylcholine.

13
New cards

Acetylcholine Degradation Enzyme

Acetylcholinesterase degrades ACh into acetic acid and choline.

14
New cards

Ionotropic Receptors

Open (chemically-gated) ion channels.

15
New cards

Metabotropic Receptors

Activate second messenger pathways.

16
New cards

Nicotinic Acetylcholine Receptor (nAChR)

Allows cations to enter the neuron upon transmitter binding; ionotropic receptor.

17
New cards

Muscarinic Acetylcholine Receptor (mAChR)

Coupled via G-proteins to different effectors; metabotropic receptor.

18
New cards

Adrenergic receptor subtypes: α1

Activates phospholipase C, producing IP3 and DAG.

19
New cards

Adrenergic receptor subtypes: α2

Inhibits adenylate cyclase, decreasing cAMP.

20
New cards

Adrenergic receptor subtypes: β1- β3

Activates adenylate cyclase, increasing cAMP.

21
New cards

Somatic Motor Pathway

Control skeletal muscle.

22
New cards

Neurotransmitter at Neuromuscular Junction

ACh acts on nicotinic ACh receptors on skeletal muscle.

23
New cards

Autonomic Nervous System

Controls involuntary actions.

24
New cards

Somatic Nervous System

Controls voluntary actions.

25
New cards

Autonomic Nervous System Transmitters

ACh and NA primary transmitters.

26
New cards

Somatic Nervous System Transmitters

Mainly ACh primary transmitter.

27
New cards

Myasthenic Disorders

A broad group of disorders of neuromuscular transmission; muscular weakness and fatigability.

28
New cards

Myasthenia Gravis (MG)

Auto-antibodies attack protein subunits of the nicotinic ACh receptor.

29
New cards

Lambert-Eaton Myasthenia (LEMS)

Auto-antibodies attack voltage gated Ca++ channels in the motor neuron presynaptic terminal.

30
New cards

ACh Receptor Deficiency

Mutations in genes encoding nicotinic ACh receptor subunits.

31
New cards

Congenital Myasthenic Syndrome with Episodic Apnea (CMSEA)

Mutations in choline acetyltransferase, the ACh synthetic enzyme.

32
New cards

End Plate Acetylcholinesterase Deficiency

Mutations in acetylcholinesterase.

33
New cards

Neurotransmitter Imbalance in Depression

Associated with imbalances in activity of central monoaminergic and cholinergic pathways in limbic system.

34
New cards

Drug Treatments for Depression

Tricyclic antidepressants, SSRIs, MAO inhibitors